SCHEMBL6348358

SCHEMBL6348358

Cc1ccc(S(=O)(=O)Nc2ccc(C(=O)Nc3ccc(Br)cc3C(=O)O)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.71
PTGES O14684 1/20 0.59
ALOX5 P09917 1/20 0.59
GPR27 Q9NS67 2/20 0.57
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
GFER P55789 2/20 0.57
RPA1 P27694 1/20 0.57
MAPT P10636 3/20 0.56
ALDH1A1 P00352 2/20 0.56
HTT P42858 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
HPGD P15428 2/20 0.56
LMNA P02545 1/20 0.56
GBA1 P04062 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
SNCA P37840 1/20 0.53
NAMPT P43490 1/20 0.52
KDM1A O60341 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349460 0.92 MEN1 (0.60) METAP2PTGESALOX5GPR27MEN1
SCHEMBL6350610 0.90 MEN1 (0.69) METAP2PTGESALOX5GPR27MEN1
SCHEMBL6352359 0.89 METAP2 (0.71) METAP2GPR27MEN1KMT2AGFER
SCHEMBL6352083 0.89 METAP2 (0.67) METAP2PTGESALOX5GPR27MEN1
SCHEMBL6355569 0.86 METAP2 (0.52) METAP2GPR27MEN1KMT2AGFER
SCHEMBL6353396 0.85 RPA1 (0.58) METAP2MEN1KMT2AGFERRPA1
SCHEMBL6352340 0.84 METAP2 (0.55) METAP2GPR27MEN1KMT2AGFER
SCHEMBL6353431 0.84 CCR9 (0.58) METAP2GPR27MEN1KMT2AGFER
SCHEMBL19083016 0.84 METAP2 (1.00) METAP2HTTLMNAKDM1ASLC10A2
SCHEMBL27180710 0.83 MEN1 (0.62) PTGESALOX5GPR27MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 METAP2 1269/4885PTGES 1428/4885ALOX5 1752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.